{
    "code": "06015164",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06015164",
    "time": "2020-10-16 09:00:11",
    "許可證字號": "衛署醫器輸字第015164號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD5514",
    "有效日期": "114\/12\/01",
    "發證日期": "94\/12\/01",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00601516408",
    "中文品名": "亞培〝設計師〞游離三碘甲狀腺素檢驗試劑",
    "英文品名": "ABBOTT ARCHITECT Free T3",
    "效能": "化學冷光微粒免疫分析法(CMIA)，可用來定量測試人類血清及血漿中的游離三碘甲狀腺素(free triiodothyronine，Free T3)。",
    "醫器規格": "#6C48：100 Tests\/400 Tests\/2000 Tests。\r\n申請變更項目：\r\n(一)新增規格：7K63-35，以下空白。\r\n(二)仿單、標籤變更。(原95.9.25核准之仿單、標籤核定本予以回收作廢)。\r\n規格變更為：7K63-20、7K63-25、7K63-30、7K63-35、7K63-01、7K63-10、7K63-27、7K63-32、7K63-37、7K63-02、7K63-12。以下空白。\r\n新增仿單標籤：詳如中文仿單核定本。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1710總三碘甲狀腺素試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MIE0064000  ABBOTT IRELAND DIAGNOSTICS DIVISION",
            "製造廠廠址": "LISNAMUCK, LONGFORD, CO. LONGFORD, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "1076804347變更核定本-107-11-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06015164&Seq=016&Type=9"
        },
        {
            "title": "1076804347變更核定本-107-11-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06015164&Seq=006&Type=8"
        }
    ]
}